Sotiris advises senior leaders of FORTUNE500 medical technology companies on portfolio planning, customer insight analysis and solutions development processes to support the design of growth initiatives.
Sotiris worked as a Senior Consultant at GfK Bridgehead, where he helped biopharma and Med Tech clients to develop programmatic commercial strategies for innovative technologies. Sotiris began his career at the IMS Consulting Group.
He has chaired and presented world-leading empirical research on explaining trends of resource acquisition under technological uncertainty, and is a member of the Strategic Management Society.
Sotiris received his PhD in Corporate Strategy from Warwick Business School (University of Warwick), where he was an Economic and Social Research Council (ESRC) Fellow, and an MSc in International Health Management from Imperial College London in the UK.